Taro Pharmaceutical Industries Ltd expected to post earnings of 92  cents a share - Earnings Preview

Taro Pharmaceutical Industries

14/05/2021 12:14

* Taro Pharmaceutical Industries Ltd  TARO.N   TARO.K  is
expected to show a fall in quarterly revenue when it reports
results on May 17 (estimated) .
* The Haifa, Israel-based company is expected to report   a
15.8% decrease in revenue to $147.326 million from $174.94
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Taro Pharmaceutical
Industries Ltd is for earnings of 92 cents per share. For the
same quarter last year, the company reported earnings of $1.42
per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $81​, about 10.5% above​ its
last closing price of $72.50. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  1.01        1.01       0.86      Missed  -14.9
 Sep. 30 2020  0.77        0.77       1.18      Beat    53.2
 Jun. 30 2020  1.16        1.16       -11.37    Missed  -1,080
                                                        .2​
 Mar. 31 2020  1.53        1.53       1.42      Missed  -7.2
 Dec.          1.54​       1.54       1.76      Beat    14.3​
 31​ 2019​                                              
 Sep. 30 2019  1.72        1.72       1.46      Missed  -15.1​
 Jun. 30 2019  1.96        1.96       1.72      Missed  -12.2
 Mar. 31 2019              2.26       1.52      Missed  -32.7
 This summary was machine generated May 14 at 11:14 GMT.  All
figures in US dollars unless otherwise stated